ZOSANO PHARMA CORP's ticker is ZSAN and the CUSIP is 98979H202.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $24,000 | -96.1% | 77,663 | -97.1% | 0.02% | -94.8% |
| Q1 2022 | $612,000 | -52.1% | 2,718,226 | 0.0% | 0.33% | -26.8% |
| Q4 2021 | $1,278,000 | -34.7% | 2,718,226 | 0.0% | 0.45% | +15.6% |
| Q3 2021 | $1,956,000 | -24.3% | 2,718,226 | 0.0% | 0.39% | -5.8% |
| Q2 2021 | $2,583,000 | -23.4% | 2,718,226 | 0.0% | 0.41% | -31.8% |
| Q1 2021 | $3,371,000 | +135.2% | 2,718,226 | 0.0% | 0.61% | +146.7% |
| Q4 2020 | $1,433,000 | -67.5% | 2,718,226 | 0.0% | 0.25% | -82.5% |
| Q3 2020 | $4,404,000 | +89.2% | 2,718,226 | 0.0% | 1.41% | +58.4% |
| Q2 2020 | $2,328,000 | +52.4% | 2,718,226 | 0.0% | 0.89% | +33.3% |
| Q1 2020 | $1,528,000 | -63.0% | 2,718,226 | 0.0% | 0.67% | -57.9% |
| Q4 2019 | $4,132,000 | +30.6% | 2,718,226 | +34.0% | 1.58% | -4.1% |
| Q3 2019 | $3,165,000 | -52.3% | 2,028,571 | 0.0% | 1.65% | -41.8% |
| Q2 2019 | $6,633,000 | -13.1% | 2,028,571 | +26.8% | 2.83% | -51.3% |
| Q1 2019 | $7,632,000 | +125.0% | 1,600,000 | 0.0% | 5.81% | +62.7% |
| Q4 2018 | $3,392,000 | – | 1,600,000 | – | 3.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 1,172,542 | $1,900,000 | 1.90% |
| Aisling Capital Management LP | 2,718,226 | $4,404,000 | 1.41% |
| Telemetry Investments, L.L.C. | 239,830 | $389,000 | 0.84% |
| Sio Capital Management, LLC | 452,542 | $733,000 | 0.14% |
| AJ WEALTH STRATEGIES, LLC | 136,476 | $221,000 | 0.02% |
| CAAS CAPITAL MANAGEMENT LP | 453,168 | $734,000 | 0.02% |
| Highlander Capital Management, LLC | 10,000 | $16,000 | 0.01% |
| Qube Research & Technologies Ltd | 427,894 | $693,000 | 0.01% |
| Alyeska Investment Group, L.P. | 295,953 | $479,000 | 0.01% |
| WINTON GROUP Ltd | 120,182 | $195,000 | 0.01% |